Nigeria Launches Twice-Yearly HIV Prevention Injection

A breakthrough HIV prevention method just launched in Nigeria's Benue State, where nearly 200,000 people live with the virus. The new drug, Lenacapavir, requires just two injections per year instead of daily pills.

For years, HIV prevention relied on daily oral medication that saved countless lives but came with real challenges. People struggled with daily adherence, faced stigma picking up prescriptions, and found the routine difficult to maintain.

Now, twice-yearly injections offer a discreet, convenient alternative. Benue State Health Commissioner Paul Ogwuche calls the launch "a major milestone" in the region's fight against AIDS.

The timing matters deeply for Benue State. With 195,305 people currently receiving HIV treatment, it carries the heaviest treatment burden of any Nigerian state, surpassing even Lagos.

The state's HIV prevalence stands at 4.7 percent, among the nation's highest rates. That reality makes innovative prevention approaches not just helpful but necessary.

The program will prioritize those most at risk: adolescent girls, young women, key populations, and serodiscordant couples where one partner has HIV and the other doesn't. Both urban and rural communities will have access to the injections.

Implementation will run through the State AIDS and STI Control Programme, working alongside civil society organizations and community networks. Healthcare workers in Makurdi, Otukpo, Gboko, Aliade, and other areas have already begun supporting the rollout.

Multiple organizations joined forces to make this happen. The World Health Organization, AIDS Prevention Initiative in Nigeria, AIDS Healthcare Foundation, Clinton Health Access Initiative, Tearfund, and RedAid Nigeria collaborated on the launch.

The Ripple Effect

This launch reaches far beyond Benue State. Nationwide, about 1.7 million Nigerians currently receive HIV treatment, and the new prevention option could dramatically reduce new infections across the country.

The success in Benue creates a model for other high-burden states. Akwa Ibom and Lagos, with 158,201 and 135,918 patients respectively, could follow with similar programs.

Young women and girls stand to benefit most from the discreet injection format. Without the daily reminder or pharmacy visits, prevention becomes easier to maintain privately.

Permanent Secretary Cephas Hough emphasizes that while the injectable represents scientific progress, awareness campaigns and education remain crucial. The medical breakthrough works best when combined with community knowledge and engagement.

The initiative aligns with Nigeria's commitment to end AIDS by 2030. With innovative prevention tools now available, that ambitious goal moves closer to reality.

Governor Hyacinth Alia's health agenda prioritizes protecting vulnerable populations and improving healthcare access, and Lenacapavir delivery on both fronts strengthens the state's public health infrastructure for years to come.

#